GALECTIN THERAPEUTICS INC — Director's Dealing 2019

Jan 24, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2019-01-21

Reporting Person: AMELIO GILBERT F (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-01-21	Common Stock	M	41500	$.89	Acquired	161461	Direct
2019-01-21	Common Stock	F	7776	$4.75	Disposed	153685	Direct
2019-01-21	Common Stock	M	62250	$2.39	Acquired	215935	Direct
2019-01-21	Common Stock	F	31322	$4.75	Disposed	184614	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-21	Stock option (right to buy)	$.89	M	41500	Disposed	2026-12-15	Common Stock (41500)	Direct
2019-01-21	Stock option (right to buy)	$2.39	M	62250	Disposed	2027-12-14	Common Stock (62250)	Direct

Footnotes

F1: The options vested 100% on December 14, 2017.

F2: The options vested 100% on December 14, 2018.